We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Accelerating Typhoid Conjugate Vaccine Introduction: What Can Be Learned From Prior New Vaccine Introduction Initiatives?
- Authors
Jamka, Leslie P; Simiyu, Kenneth W; Bentsi-Enchill, Adwoa D; Mwisongo, Aziza J; Matzger, Helen; Marfin, Anthony A; Pollard, Andrew J; Neuzil, Kathleen M
- Abstract
The health consequences of typhoid, including increasing prevalence of drug-resistant strains, can stress healthcare systems. While vaccination is one of the most successful and cost-effective health interventions, vaccine introduction can take years and require considerable effort. The Typhoid Vaccine Acceleration Consortium (TyVAC) employs an integrated, proactive approach to accelerate the introduction of a new typhoid conjugate vaccine to reduce the burden of typhoid in countries eligible for support from Gavi, the Vaccine Alliance. TyVAC and its partners are executing a plan, informed by prior successful vaccine introductions, and tailored to the nuances of typhoid disease and the typhoid conjugate vaccine. The iterative process detailed herein summarizes the strategy and experience gained from the first 2 years of the project.
- Subjects
AFRICA; ASIA; TYPHOID fever; TYPHOID vaccines; DRUG resistance in microorganisms; HEALTH promotion; IMMUNIZATION; INTERPROFESSIONAL relations; PREVENTION; VACCINES
- Publication
Clinical Infectious Diseases, 2019, Vol 68, pS171
- ISSN
1058-4838
- Publication type
Article
- DOI
10.1093/cid/ciy1118